A new laboratory study highlights three critical findings about synthetic cooling agents in e-cigarettes that consumers and healthcare providers should understand. First, these cooling compounds—distinct from natural menthol—directly cause abnormal heartbeats in experimental cardiac models. Second, the effect appears consistent across different biological systems, affecting both intact organ models and isolated human heart cells equally.
Third, and perhaps most importantly, this research demonstrates cardiovascular risks from e-cigarette ingredients beyond nicotine dependence. While laboratory findings do not automatically translate to human health outcomes, the evidence is substantial enough to warrant caution, particularly among vulnerable populations such as adolescents and individuals with pre-existing cardiac conditions.
Healthcare providers should consider discussing these emerging risks with patients who use e-cigarettes. The research underscores the importance of understanding exactly what compounds consumers are inhaling and the potential long-term cardiovascular implications of regular exposure to novel synthetic additives.
Read the full article on GMJ Newsroom.
Was this article helpful?
